Remote Patient Monitoring

Chapter Outlines

Chapter 2 is an executive summary of key insights captured in our research. It offers a high-level view on the current state of remote patient monitoring market and its likely evolution in the mid to long term. 
 
Chapter 3 provides a general introduction to remote patient monitoring tools and software, featuring details related to the current and future trends in the domain. It further includes a brief introduction to the concept of telemedicine and its types, along with information on the need for software systems in this domain, along with the various patient monitoring related services offered by players. Furthermore, it highlights prevalent regulatory guidelines, as well as advantages and risks associated with the use of such tools and software. 
 
Chapter 4 provides a detailed review of the overall market landscape of players engaged in providing remote patient monitoring consultation tools and software, along with the information on several relevant parameters, such as year of establishment, company size, location of headquarters. Further, it highlights a detailed assessment of the overall market landscape of more than 200 consultation tools and software based on several relevant parameters, such as type of software (software as a system and software as a service), area of  application (blood glucose, blood pressure, electrocardiogram (ECG), oxygen saturation, respiration rate, temperature, and others), therapeutic areas (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and other disorders), product / software purpose (commercial purpose and clinical study purpose), type of telemedicine operation (store-and-forward, remote monitoring, and real-time), type of remote patient monitoring service (data collection, transmission, evaluation, and notification), type of business model (B2B and B2C).  

Chapter 5 features elaborate profiles of prominent players (shortlisted based on number of software being offered by mid-sized and large players established before 2010) engaged in the development of remote patient monitoring software. Each company profile features a brief overview of the company, along with information on its year of establishment, number of employees, location of headquarters, key executives, financial details / information (if available), product portfolio, recent developments and an informed future outlook.

Chapter 6 features an analysis of the recent partnerships inked between remote patient monitoring software providers, during the period 2015-2021 Additionally, it includes a brief description of the various types of partnerships models (such as product / software integration agreement, service alliance, service agreement, product / software development agreement, full business acquisition, product / software distribution agreement, product / software utlilization agreement, and product portfolio acquisition) that have been adopted by stakeholders engaged in this domain, during the period 2015-2021.

Chapter 7 provides an analysis of various investments made by players engaged in this domain based on several relevant parameters, such as year of investment, number of funding instances, amount invested and type of funding (such as, venture capital, private equity, secondary offerings, debt, initial public offering (IPO), other equity, seed, grant, and others), along with information on the most active players (in terms of number of funding instances and amount raised) and most active investors (in terms of number of funding instances).

Chapter 8 features an in-depth product competitiveness analysis of remote patient monitoring software based on supplier power (in terms of expertise of the developer) and key product-related specifications (such as status of development, HIPPA compliant, type of software, area(s) of application, number of therapeutic areas, purpose of software, number of patient monitoring related services, type of telemedicine operation, and type of business model).

Chapter 9 presents insights from an insightful analysis highlighting the likely cost saving potential associated with the use of remote patient monitoring consultation tools and software solutions, taking into consideration various parameters, such as number of patient visits (in-patient and out-patient) and increase in efficiency by adoption of remote patient monitoring software solutions.

Chapter 10 features a detailed market forecast analysis, highlighting the likely evolution of the market in the short to mid-term and long term, for the period 2021-2030. Additionally, the report features the likely distribution of the current and forecasted opportunity across [A] area of  application (blood glucose, blood pressure, ECG, oxygen saturation, respiration rate, temperature, and others) [B] target therapeutic area (cardiovascular disorders, infectious diseases, metabolic disorders, oncological disorders, respiratory disorder, and others), [C] software purpose (commercial purpose and clinical study purpose), [D] type of business model (B2B and B2C), and [E] key geographical regions (North America, Europe, Asia-Pacific, Latin America, and MENA (Middle East and North Africa)). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

Chapter 11 features an insightful discussion on how the recent COVID-19 pandemic is likely to impact the remote patient monitoring software market, along with information on the key initiatives undertaken by the developers engaged in this domain to overcome the challenges faced due to the pandemic.

Chapter 12 provides a detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall remote patient monitoring tools and software providers industry.

Chapter 13 is a summary of the entire report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 14 is a collection of interview transcripts of the discussion(s) that were held key stakeholders in the industry. 

Chapter 15 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 16 is an appendix, which contains a list of companies and organizations mentioned in this report.

Table Of Contents

 1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION 
3.1. Chapter Overview
3.2. Introduction to Telemedicine
3.2.1. Store-and-Forward Telemedicine
3.2.2. Real-Time Telemedicine
3.2.3. Telemedicine in Remote Patient Monitoring  
3.3. Advantages of Remote Patient Monitoring
3.4. Limitations Associated with Remote Patient Monitoring
3.5. Regulatory Considerations for Remote Patient Monitoring Solutions
3.6. Concluding Remarks

4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Remote Patient Monitoring Consultation Tools and Software: Overall Market Landscape
4.2.1. Analysis by Type of Software
4.2.2. Analysis by Purpose of Software
4.2.3. Analysis by Area of Application
4.2.4. Analysis by Therapeutic Area
4.2.5. Analysis by Type of Telemedicine Operation
4.2.6. Analysis by Type of Remote Patient Monitoring Service Offered
4.2.7. Analysis by Type of Business Model

4.3. Remote Patient Monitoring Consultation Tools and Software: Solution Providers Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters

5. COMPANY PROFILES
5.1. Chapter Overview 
5.2. Players based in North America
5.2.1. BioTelemetry
5.2.1.1. Company Overview
5.2.1.2. Financial Information
5.2.1.3. Software Portfolio
5.2.1.4. Future Outlook

5.2.2. LeewayHertz
5.2.2.1. Company Overview
5.2.2.2. Software Portfolio
5.2.2.3. Future Outlook

5.2.3. Masimo
5.2.3.1. Company Overview
5.2.3.2. Financial Information
5.2.3.3. Software Portfolio
5.2.3.4. Future Outlook

5.3. Players based in Europe
5.3.1. Braster
5.3.1.1. Company Overview
5.3.1.2. Software Portfolio
5.3.1.3. Future Outlook

5.3.2. LifeWatch
5.3.2.1. Company Overview
5.3.2.2. Software Portfolio
5.3.2.3. Future Outlook

5.3.3. Medtronic
5.3.3.1. Company Overview
5.3.3.2. Financial Information
5.3.3.3. Software Portfolio
5.3.3.4. Future Outlook

5.3.4. Siemens Healthineers
5.3.4.1. Company Overview
5.3.4.2. Financial Information
5.3.4.3. Software Portfolio
5.3.4.4. Future Outlook

5.4. Players based in Asia-Pacific
5.4.1. Transtek Medical
5.4.1.1. Company Overview
5.4.1.2. Financial Information
5.4.1.3. Software Portfolio
5.4.1.4. Future Outlook

6. PARTNERSHIPS AND COLLABORATIONS
6.1. Chapter Overview
6.2. Partnership Models

6.3. Remote Patient Monitoring Consultation Tools and Software Providers: Recent Partnerships and Collaborations
6.3.1. Analysis by Year of Partnership
6.3.2. Analysis by Type of Partnership
6.3.2.1. Analysis by Year and Type of Partnership
6.3.2.2. Analysis by Type of Partnership and Company Size

6.3.3. Analysis by Type of Software
6.3.3.1. Analysis by Year of Partnership and Type of Software
6.3.3.2. Analysis by Type of Partnership and Type of Software

6.3.4. Most Active Players: Analysis by Number of Partnerships
6.3.5. Regional Analysis
6.3.5.1. Intercontinental and Intracontinental Agreements

7. FUNDING AND INVESTMENT ANALYSIS
7.1. Chapter Overview
7.2. Types of Funding

7.3. Remote Patient Monitoring Consultation Tools and Software Providers: Funding and Investment Analysis
7.3.1. Analysis by Cumulative Year-wise Trend, 2015 - 2021
7.3.2. Analysis by Amount Invested
7.3.3. Analysis by Type of Funding
7.3.3.1. Analysis by Type of Venture Capital Round
7.3.4. Analysis by Type of Software
7.3.5. Analysis by Focus Area
7.3.6. Analysis by Geography
7.3.7. Most Active Players: Analysis by Number of Instances
7.3.8. Most Active Players: Analysis by Amount Invested
7.3.9. Most Active Investors: Analysis by Number of Instances
7.3.10. Analysis by Year, Amount Invested and Type of Investor

7.4. Concluding Remarks

8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Methodology 
8.3. Assumptions / Key Parameters
8.4. Product Competitiveness: Software as a Service
8.5. Product Competitiveness: Software as a System

9. COST SAVING ANALYSIS
9.1. Chapter Overview
9.2. Key Assumptions and Methodology

9.3. Remote Patient Monitoring Solutions: Overall Cost Saving Potential 
9.3.1. Likely Cost Savings in North America, 2021-2030
9.3.2. Likely Cost Savings in Europe, 2021-2030
9.3.3. Likely Cost Savings in Asia, 2021-2030
9.3.4. Likely Cost Savings in Rest of the World, 2021-2030

9.4. Conclusion

10. MARKET FORECAST
10.1. Chapter Overview
10.2. Forecast Methodology and Key Assumptions
10.3. Global Remote Patient Monitoring Consultation Tools and Software Providers Market, 2021-2030
10.4. Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Area of Application
10.4.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Glucose, 2021-2030
10.4.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Blood Pressure, 2021-2030
10.4.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for ECG, 2021-2030
10.4.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oxygen Saturation, 2021-2030
10.4.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiration Rate, 2021-2030
10.4.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Body Temperature, 2021-2030
10.4.7. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Areas of Application, 2021-2030

10.5. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Therapeutic Area
10.5.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Cardiovascular Disorders, 2021-2030
10.5.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Infectious Diseases, 2021-2030
10.5.3. Remote Patient Monitoring Consultation Tools and Software Providers Market for Metabolic Disorders, 2021-2030
10.5.4. Remote Patient Monitoring Consultation Tools and Software Providers Market for Oncological Disorders, 2021-2030
10.5.5. Remote Patient Monitoring Consultation Tools and Software Providers Market for Respiratory Disorders, 2021-2030
10.5.6. Remote Patient Monitoring Consultation Tools and Software Providers Market for Other Therapeutic Areas, 2021-2030

10.6. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Purpose of Software
10.6.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for Clinical Studies, 2021-2030
10.6.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for Commercial Purposes, 2021-2030

10.7. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Type of Business Model
10.7.1. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2B, 2021-2030
10.7.2. Remote Patient Monitoring Consultation Tools and Software Providers Market for B2C, 2021-2030

10.8. Global Remote Patient Monitoring Consultation Tools and Software Providers Market: Distribution by Geography
10.8.1. Remote Patient Monitoring Consultation Tools and Software Providers Market in North America, 2021-2030
10.8.2. Remote Patient Monitoring Consultation Tools and Software Providers Market in Europe, 2021-2030
10.8.3. Remote Patient Monitoring Consultation Tools and Software Providers Market in Asia-Pacific, 2021-2030
10.8.4. Remote Patient Monitoring Consultation Tools and Software Providers Market in Middle-East and North Africa (MENA), 2021-2030
10.8.5. Remote Patient Monitoring Consultation Tools and Software Providers Market in Latin America, 2021-2030

11. IMPACT OF COVID-19 PANDEMIC ON DIGITAL SOLUTIONS FOR BIOMARKERS MARKET
11.1. Chapter Overview
11.2. Impact of COVID-19 on Telemedicine and Remote Patient Monitoring
11.2.1. Impact on Future Market Opportunity for Remote Patient Monitoring
11.3. Recuperative Initiatives of Key Players

11.4. Recuperative Strategies for Businesses
11.4.1. Strategies for Implementation in the Short / Mid Term
11.4.2. Strategies for Implementation in the Long Term

12. SWOT ANALYSIS
12.1. Chapter Overview
12.2. Strengths
12.3. Weaknesses
12.4. Opportunities
12.5. Threats
12.6. Comparison of SWOT Factors

13. CONCLUSION

14. INTERVIEW TRANSCRIPTS
14.1. Chapter Overview
14.2. AltumView System
14.2.1. Company Snapshot
14.2.2. Survey Transcript: John Wu, Co-Founder

15. APPENDIX I: TABULATED DATA

16. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures 

Figure 3.1 Type of Telemedicine
Figure 3.2 Steps Involved in Remote Patient Monitoring
Figure 3.3 Key Benefits and Limitations of RPM Solutions
Figure 4.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Figure 4.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Figure 4.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Figure 4.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Figure 4.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Figure 4.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Figure 4.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Figure 4.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Figure 4.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Figure 4.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Figure 4.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Figure 4.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Figure 4.13 Stacked Bar Chart Representation: Distribution by Type of Software and Area of Application
Figure 5.1 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Figure 5.2 Masimo: Annual Revenues, 2015-2021 (USD Million)
Figure 5.3 Medtronic: Annual Revenues, 2015-2021 (USD Million)
Figure 5.4 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Figure 5.5 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Figure 6.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 6.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 6.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 6.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 6.5 Partnerships and Collaborations: Distribution by Type of Software
Figure 6.6 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Figure 6.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Figure 6.8 Most Active Players: Distribution by Number of Partnerships
Figure 6.9 Partnerships and Collaborations: Regional Distribution
Figure 6.10 Partnerships and Collaborations: Country-wise Distribution
Figure 6.11 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 7.1 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Figure 7.2 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Figure 7.3 Funding and Investment Analysis: Distribution by Type of Funding
Figure 7.4 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Figure 7.5 Funding and Investment Analysis: Distribution by Year and Type of Funding
Figure 7.6 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Figure 7.7 Funding and Investment Analysis: Distribution by Type of Investor
Figure 7.8 Funding and Investment Analysis: Distribution by Type of Software
Figure 7.9 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Figure 7.10 Funding and Investment Analysis: Distribution by Focus Area
Figure 7.11 Funding and Investment Analysis: Distribution by Geography
Figure 7.12 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Figure 7.13 Most Active Players: Distribution by Number of Instances
Figure 7.14 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 7.15 Most Active Investors: Distribution by Number of Instances
Figure 7.16 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Figure 8.1 Product Competitiveness Analysis: Software as a Service
Figure 8.2 Product Competitiveness Analysis: Software as a System
Figure 9.1 Overall Cost Saving Potential Associated with Remote Patient Monitoring Solutions, 2021-2030 (USD Million)
Figure 9.2 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2030 (USD Million)
Figure 9.3 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2030 (USD Million)
Figure 9.4 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2030 (USD Million)
Figure 9.5 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2030 (USD Million)
Figure 10.1 Global Remote Patient Monitoring Consultation Tools and Software Market, 2021-2030 (USD Million)
Figure 10.2 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2030
Figure 10.3 Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2030 (USD Million)
Figure 10.4 Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2030 (USD Million)
Figure 10.5 Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2030 (USD Million)
Figure 10.6 Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2030 (USD Million)
Figure 10.7 Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2030 (USD Million)
Figure 10.8 Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2030 (USD Million)
Figure 10.9 Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2030 (USD Million)
Figure 10.10 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2030
Figure 10.11 Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2030 (USD Million)
Figure 10.12 Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2030 (USD Million)
Figure 10.13 Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2030 (USD Million)
Figure 10.14 Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2030 (USD Million)
Figure 10.15 Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2030 (USD Million)
Figure 10.16 Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2030 (USD Million)
Figure 10.17 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2030
Figure 10.18 Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2030 (USD Million)
Figure 10.19 Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2030 (USD Million)
Figure 10.20 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2030
Figure 10.21 Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2030 (USD Million)
Figure 10.22 Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2030 (USD Million)
Figure 10.23 Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2030
Figure 10.24 Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2030 (USD Million)
Figure 10.25 Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2030 (USD Million)
Figure 10.26 Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2030 (USD Million)
Figure 10.27 Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2030 (USD Million)
Figure 10.28 Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2030 (USD Million)
Figure 11.1 Remote Patient Monitoring Market, 2021-2030: COVID-19 Impact Scenario (USD Million)
Figure 11.2 Key RPM Consultation Tools and Software Providers
Figure 12.1 Remote Patient Monitoring Consultation Tools and Software Providers: SWOT Analysis
Figure 12.2 Comparison of SWOT Factors: Harvey Ball Analysis
Figure 13.1 Concluding Remarks: Current Market Landscape
Figure 13.2 Concluding Remarks: Recent Partnerships
Figure 13.3 Concluding Remarks: Funding Analysis
Figure 13.4 Concluding Remarks: Cost Saving Analysis
Figure 13.5 Concluding Remarks: Market Sizing and Opportunity Analysis
Figure 13.6 Concluding Remarks: Market Sizing and Opportunity Analysis by Geography

List Of Tables

Table 4.1 Remote Patient Monitoring Consultation Tools and Software: Information on Status of Software Development, Approved Countries, HIPAA Compliance and Software Specification
Table 4.2 Remote Patient Monitoring Consultation Tools and Software: Information on Area of Application
Table 4.3 Remote Patient Monitoring Consultation Tools and Software: Information on Therapeutic Area
Table 4.4 Remote Patient Monitoring Consultation Tools and Software: Information on Purpose of Software and Type of Business Model
Table 4.5 Remote Patient Monitoring Consultation Tools and Software: Information on Type of Telemedicine Operation and Patient Monitoring Related Services
Table 4.6 Remote Patient Monitoring Consultation Tools and Software: Information on Year of Establishment, Company Size and Location of Headquarters
Table 5.1 BioTel Care: Company Overview
Table 5.2 BioTel Care: Software Portfolio
Table 5.3 BioTel Care: Future Outlook
Table 5.4 LeewayHertz: Company Overview
Table 5.5 LeewayHertz: Software Portfolio
Table 5.6 Masimo: Company Overview
Table 5.7 Masimo: Software Portfolio
Table 5.8 Masimo: Future Outlook
Table 5.9 Braster: Company Overview
Table 5.10 Braster: Software Portfolio
Table 5.11 LifeWatch: Company Overview
Table 5.12 LifeWatch: Software Portfolio
Table 5.13 LifeWatch: Future Outlook
Table 5.14 Medtronic: Company Overview
Table 5.15 Medtronic: Software Portfolio
Table 5.16 Medtronic: Future Outlook
Table 5.17 Siemens Healthineers: Company Overview
Table 5.18 Siemens Healthineers: Software Portfolio
Table 5.19 Siemens Healthineers: Future Outlook
Table 5.20 Transtek Medical: Company Overview
Table 5.21 Transtek Medical: Software Portfolio
Table 5.22 Transtek Medical: Future Outlook
Table 6.1 Partnerships and Collaborations: Information on Partner, Year of Partnership, Type of Partnership and Type of Software, 2015-2021
Table 7.1 Fundings and Investments: Information on Type of Funding, Year of Investment, Amount Invested and Lead Investors, 2015-2021
Table 7.2 Funding and Investment Analysis: Summary of Investments
Table 7.3 Funding and Investment Analysis: Summary of Venture Capital Round
Table 7.4 Fundings and Investments: Information on Year of Establishment, Location of Headquarters of Recipients, Software, Type of Software, and Focus Area
Table 13.1 Remote Patient Monitoring Consultation Tools and Service Providers: List of RPM Software Focused on COVID-19 Patient Monitoring
Table 13.2 Remote Patient Monitoring Consultation Tools and Service Providers: Information on Partnerships Focused on COVID-19
Table 14.1 AltumView System: Company Snapshot
Table 15.1 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Software
Table 15.2 Remote Patient Monitoring Consultation Tools and Software: Distribution by Purpose of Software
Table 15.3 Remote Patient Monitoring Consultation Tools and Software: Distribution by Area of Application
Table 15.4 Remote Patient Monitoring Consultation Tools and Software: Distribution by Therapeutic Area
Table 15.5 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Telemedicine Operation
Table 15.6 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Remote Patient Monitoring Service Offered
Table 15.7 Remote Patient Monitoring Consultation Tools and Software: Distribution by Type of Business Model
Table 15.8 Remote Patient Monitoring Consultation Tools and Software: Distribution by Year of Establishment
Table 15.9 Remote Patient Monitoring Consultation Tools and Software: Distribution by Company Size
Table 15.10 Remote Patient Monitoring Consultation Tools and Software: Distribution by Location of Headquarters
Table 15.11 Most Active Players: Distribution by Number of Remote Patient Monitoring Solutions
Table 15.12 Tree Map Representation: Distribution by Type of Software and Therapeutic Area
Table 15.13 Heat Map Representation: Distribution by Type of Software and Area of Application
Table 15.14 BioTel Care: Annual Revenues, 2015-2021 (USD Million)
Table 15.15 Masimo: Annual Revenues, 2015-2021 (USD Million)
Table 15.16 LifeWatch: Annual Revenues, 2015-2021 (USD Million)
Table 15.17 Siemens Healthineers: Annual Revenues, 2015-2021 (USD Million)
Table 15.18 Transtek Medical: Annual Revenues, 2015-2021 (USD Million)
Table 15.19 Partnerships and Collaborations: Distribution by Year of Partnership
Table 15.20 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.21 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.22 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 15.23 Partnerships and Collaborations: Distribution by Type of Software
Table 15.24 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Software
Table 15.25 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Software
Table 15.26 Most Active Players: Distribution by Number of Partnerships
Table 15.27 Partnerships and Collaborations: Regional Distribution
Table 15.28 Partnerships and Collaborations: Country-wise Distribution
Table 15.29 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.30 Funding and Investment Analysis: Distribution by Cumulative Year-wise Trend, 2015 - 2021
Table 15.31 Funding and Investment Analysis: Distribution by Amount Invested (USD Million)
Table 15.32 Funding and Investment Analysis: Distribution by Type of Funding
Table 15.33 Funding and Investment Analysis: Distribution by Type of Venture Capital Round
Table 15.34 Funding and Investment Analysis: Distribution by Year and Type of Funding
Table 15.35 Funding and Investment Analysis: Distribution by Type of Funding and Amount Invested (USD Million)
Table 15.36 Funding and Investment Analysis: Distribution by Type of Investor
Table 15.37 Funding and Investment Analysis: Distribution by Type of Software
Table 15.38 Funding and Investment Analysis: Distribution by Type of Software and Amount Invested (USD Million)
Table 15.39 Funding and Investment Analysis: Distribution by Focus Area
Table 15.40 Funding and Investment Analysis: Distribution by Geography
Table 15.41 Funding and Investment Analysis: Distribution by Amount Invested (USD Million) and Region
Table 15.42 Most Active Players: Distribution by Number of Instances
Table 15.43 Most Active Players: Distribution by Amount Invested (USD Million)
Table 15.44 Most Active Investors: Distribution by Number of Instances
Table 15.45 Funding and Investment Analysis: Distribution by Year, Amount Invested and Type of Investor
Table 15.46 Overall Cost Saving Potential of Using Remote Patient Monitoring Solutions, 2021-2030 (USD Million)
Table 15.47 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in North America, 2021-2030 (USD Million)
Table 15.48 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Europe, 2021-2030 (USD Million)
Table 15.49 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in Asia-Pacific, 2021-2030 (USD Million)
Table 15.50 Cost Saving Potential Associated with Remote Patient Monitoring Solutions in RoW, 2021-2030 (USD Million)
Table 15.51 Global Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market, 2021-2030 (USD Million)
Table 15.52 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Area of Application, 2021 and 2030
Table 15.53 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Glucose, 2021-2030 (USD Million)
Table 15.54 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Pressure, 2021-2030 (USD Million)
Table 15.55 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Blood Temperature, 2021-2030 (USD Million)
Table 15.56 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for ECG, 2021-2030 (USD Million)
Table 15.57 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oxygen Saturation, 2021-2030 (USD Million)
Table 15.58 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiration Rate, 2021-2030 (USD Million)
Table 15.59 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Areas of Application, 2021-2030 (USD Million)
Table 15.60 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Therapeutic Area, 2021 and 2030
Table 15.61 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Cardiovascular Disorders, 2021-2030 (USD Million)
Table 15.62 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Infectious Diseases, 2021-2030 (USD Million)
Table 15.63 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Metabolic Disorders, 2021-2030 (USD Million)
Table 15.64 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Oncological Disorders, 2021-2030 (USD Million)
Table 15.65 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Respiratory Disorders, 2021-2030 (USD Million)
Table 15.66 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Other Therapeutic Areas, 2021-2030 (USD Million)
Table 15.67 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Purpose of Software, 2021 and 2030
Table 15.68 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Clinical Purpose, 2021-2030 (USD Million)
Table 15.69 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for Commercial Purposes, 2021-2030 (USD Million)
Table 15.70 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Type of Business Model, 2021 and 2030
Table 15.71 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2B, 2021-2030 (USD Million)
Table 15.72 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market for B2C, 2021-2030 (USD Million)
Table 15.73 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market: Distribution by Geography, 2021 and 2030
Table 15.74 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in North America, 2021-2030 (USD Million)
Table 15.75 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Europe, 2021-2030 (USD Million)
Table 15.76 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Asia-Pacific, 2021-2030 (USD Million)
Table 15.77 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in MENA, 2021-2030 (USD Million)
Table 15.78 Telemedicine in Remote Patient Monitoring Consultation Tools and Software Market in Latin America, 2021-2030 (USD Million)
Table 15.79 Telemedicine in Remote Patient Monitoring Market, 2021-2030: COVID-19 Impact Scenario (USD Million)

List Of Companies

The following companies and organizations have been mentioned in the report.

1. 100Plus
2. 1812 Ventures
3. 19Labs
4. 3M Ventures
5. 3one4 Capital
6. 42Gears Mobility Systems
7. 500 Startups
8. A&D Medical
9. Abbott
10. Acceleration Fund
11. AccessibleRPM
12. Acetiam
13. Adelie
14. AdvaMed Accel
15. Aerotel Medical Systems
16. Agatsa Software
17. AGNITY Healthcare
18. Ai Health Highway
19. AloT Health
20. AliveCor
21. Aloe Care Health
22. Alpana Ventures
23. AltumView Systems
24. Amadeus Capital Partners
25. AMC Health
26. American Heart Association (AHA)
27. AMN Healthcare
28. Amwell
29. Anathem Ventures
30. Anelto
31. Anges Québec
32. Anthem Capital
33. Aperture Venture Partners
34. Aphelion Capital
35. Archimedia
36. ARTIS Ventures
37. Asahi Intecc
38. Ascension Ventures
39. Ascent Biomedical Ventures
40. Ascom
41. AstraZeneca
42. athenahealth
43. Atlantic Bridge
44. Audicor Cardiometrics
45. Aurora Health Care
46. Aviva Ventures
47. AVS Medical
48. Axilor
49. Babylon Health
50. Babyscripts
51. Bank of the Philippine Islands (BPI)
52. Bardy Diagnostics
53. Baxter Ventures
54. Bayer
55. BDC Capital
56. BeatO
57. Ben Franklin Technology Partners
58. BettrLife
59. Bill & Melinda Gates Foundation
60. BioAdvance
61. Biobeat
62. Biofourmis
63. BioIntelliSense
64. BioNTech
65. BioSerenity
66. Biotechnology Industry Research Assistance Council
67. BioTel Care
68. BioTelemetry
69. Biotricity
70. Bizmatics
71. Black Pearl Global Investments
72. Blue Cross Blue Shield
73. Blue Spark Technologies
74. Blume Ventures
75. BNP Paribas Développement
76. Bold Capital Partners
77. Bonfire Ventures
78. Boston Scientific
79. Bpifrance
80. Brainpan Innovations
81. Braster
82. Bristol Myers Squibb
83. Cambia Health Solutions
84. Canaan Partners
85. Capital Factory
86. Capsule Technologies
87. CAPTUREPROOF
88. Cardinal Health
89. Cardiomo
90. Cardiotrack
91. Cardiovascular Systems
92. Care Innovations
93. CareClix
94. Caregility
95. Carematix
96. CareMonitor
97. CarePICS
98. CareSignal
99. CareSimple
100. Catex Health
101. Cathexis Ventures
102. Centre for Development of Advanced Computing (C-DAC)
103. Cerner
104. Certintell
105. CG Health Ventures
106. ChartSpan
107. Chiron Health
108. ChronicWatch
109. ChroniSense Medical
110. Claris Healthcare
111. Cloud DX
112. Cohero Health
113. Comarch 
114. Compass Medical
115. Contact Doctor Healthcare
116. Cover2protect
117. Cultivation Capital
118. Curatess
119. Curatio
120. Current Health
121. Daher Capital
122. DarioHealth
123. Dassault Systèmes
124. DaytoDay Health (DTDHI)
125. DCM Ventures
126. Delphi Ventures
127. Department of Science and Technology
128. Device Authority
129. Dexcom
130. Diagnext
131. Digital Technology Supercluster
132. Digitalis Ventures
133. DigiTx Partners
134. Diversified Healthcare Partners
135. Doccla
136. DocEngage
137. Doconvid AI
138. Dozee
139. Dräger 
140. Dreamit Ventures
141. Drimpy
142. DVI Equity Partners
143. EDBI
144. Edison Partners
145. Eko
146. Elements Health Ventures
147. Endeavour Vision
148. Enterprise Ireland
149. Envolve People Care
150. eVisit
151. Eurazeo
152. FedDev Ontario
153. FirstLight Home Care
154. Floodgate
155. Forefront Analytics
156. Fosun Pharma
157. FOUNDER.org
158. Founders Fund
159. Foundry
160. Francisco Partners
161. Fresenius Medical Care North America
162. Froedtert & the Medical College of Wisconsin 
163. Frontline Strategy
164. Frontline Ventures
165. FundersClub
166. Fuse Medical
167. Gallagher Home Health Services
168. GatewayMD
169. Georgian Partners
170. Gilde Healthcare
171. GIS Strategic Ventures
172. Global Telehealth Services
173. Glooko
174. Grapheal
175. Grazia Equity
176. Great Lakes NeuroTechnologies
177. Greenspring Associates
178. Grove Ventures
179. GrowAyu Technologies
180. GYANT
181. Hale Health
182. HAT Technologies
183. Health Catalyst Capital
184. H-Connect
185. Health Enterprise Partners
186. Health Recovery Solutions (HRS)
187. Health Sensei
188. HealthArc 
189. HealthCare Ventures
190. Healthcom
191. HealthKOS
192. HealthQuest 
193. HealthX Ventures
194. HealthyGx
195. Heitkamp & Thumann
196. Henry Schein
197. Hicuity Health
198. Highland Capital Partners
199. Higi
200. Hikma Ventures
201. Hitachi Ventures
202. HNC Virtual Solutions
203. Hoy Health
204. Huma
205. HumanITcare
206. ICON
207. iHealth Labs
208. iHealthHome
209. Implicity
210. Indian Angel Network (IAN)
211. Info360degree
212. Inhealthcare
213. Inkblot Labs
214. Innovaccer
215. Inova Health System
216. Insight Partners
217. INSUD PHARMA 
218. Insulet
219. InteliChart
220. Intermountain Ventures
221. Invest Partners
222. IOTA Informatics
223. IP Group
224. IPF Partners
225. IQ Capital
226. iRhythm Technologies
227. Isansys Lifecare
228. Itochu
229. Jianke
230. JNC Medical
231. Johnson & Johnson
232. Kaiser Permanente
233. Karantis360
234. Kayan Health
235. Keva Health
236. Khosla Ventures
237. KickstartFund
238. Kinled Holding
239. Koninklijke Philips
240. Kratin
241. Kurma Partners
242. LabCorp
243. Laboratory Silicon Valley
244. Lacuna Health
245. LBO France
246. LeewayHertz
247. Legal & General
248. Leo Capital
249. Lifelight
250. LifeWatch
251. LionBird
252. LLR Partners
253. LRVHealth
254. LSP
255. Lumeon
256. Lumira Ventures
257. m.Care
258. m.Doc Smart Clinic
259. Manchester Capital Management
260. Manorama Infosolutions
261. Maple
262. Martin Ventures
263. Masimo
264. MassChallenge
265. MassMutual Ventures
266. MAXIS Global Benefits Network
267. Mayo Clinic
268. MedAxiom
269. Medically Home
270. MediOrbis
271. MedIoTek Health Systems
272. MedM
273. MedTech Innovator
274. MEDTEQ+
275. Medtronic
276. Merisis VP
277. MicroPort CRM
278. Mindray Medical International
279. MMC Ventures
280. MobileHelp
281. Moderna
282. Mor Provident Fund
283. Mosio
284. mTelehealth
285. MTIP
286. Murata Vios
287. MVM Life Science Partners
288. MyVitalz
289. Nanowear
290. Nantahala Capital Management
291. National Institute for Health Research (NIHR)
292. National Research Council Canada 
293. National Science Foundation (NSF)
294. NemoCare Wellness
295. NeuralRays AI
296. New Enterprise Associates
297. Newark Venture Partners
298. NewYork-Presbyterian Hospital
299. NGen
300. NHSX
301. Nihon Kohden
302. Northampton General Hospital Trust
303. Northpond Ventures
304. Northwell Health
305. Norwich Ventures
306. Novo Nordisk
307. NTTVC
308. NueCura Partners
309. NWS Holdings
310. NXgenPort
311. OBS Medical
312. ODDO BHF Private Equity
313. Olipan Investments
314. Olive Tree Ventures
315. Omada Health
316. OMRON Healthcare
317. Openspace Ventures
318. OpenTeleHealth
319. OpenView Venture Partners
320. Optimize Health
321. Optum Ventures
322. Orb Health
323. OrbiMed Advisors
324. Orbita
325. Orios Venture Partners
326. OSF HealthCare
327. Oxehealth
328. Oxford Finance
329. Oxford Sciences Innovation
330. Oxitone Medical
331. P5 Health Ventures
332. Par Equity
333. Paris Saclay Seed Fund
334. PatientLink
335. Peerbridge Health
336. Perceptive Advisors
337. Peter Thiel's Founders Fund
338. Pfizer
339. Pfizer Healthcare Hub
340. PharmEasy
341. PHC Holdings
342. Philips
343. Phoenix Insurance
344. PhysIQ
345. Ping An Insurance
346. Plug and Play 
347. Podimetrics
348. Polaris Partners
349. Prairie Crest Capital
350. Prime Venture Partners
351. Promantra Synergy Solutions
352. Psagot Investment House
353. PSIM
354. PurpleRibbon Healthcare Services
355. Qardio
356. Qualcomm Life
357. Qualcomm Ventures
358. Questa Capital
359. Qumra Capital
360. Qure Ventures
361. RED Medical Systems
362. Redox
363. Reliq Health Technologies
364. Remote Care Partners
365. Resideo Life Care Solutions
366. ResMed
367. Rex Health Ventures
368. Rimidi
369. Rinicare
370. River Cities 
371. Roche
372. Rock Health
373. Rockstart 
374. RPM in a Box
375. RTP Ventures
376. SaaS Capital
377. Samsung
378. Samsung NEXT 
379. Sanford Health
380. Scientific Health Development
381. Scottish Investment Bank
382. SeamlessMD
383. Section 32
384. Senseonics
385. Sensogram Technologies
386. Sensome
387. Sequoia Capital
388. Seraph
389. SGInnovate
390. Shea Ventures
391. Shenzhen Capital
392. Siemens Healthineers
393. Silicon Valley Bank
394. Sinopharm
395. Sinovac Biotech
396. Siren
397. Smith+Nephew
398. Smiths Medical
399. Social Capital
400. SoftBank Vision Fund
401. Soleus Capital 
402. Somatix
403. Sony Innovation Fund
404. SOSV
405. Spacelabs Healthcare
406. Spectrum Health
407. Spry
408. Square 1 Bank
409. St. Luke’s Medical Center
410. StartX
411. StartUp Health
412. Stasis Labs
413. Strados Labs
414. SV Health Investors
415. Swanhill Capital
416. TaiDoc Technology
417. Technology Development Board (TDB)
418. techstars 
419. Teladoc Health
420. TeleMedCare
421. Teslon Technologies
422. Three Leaf Ventures
423. TiaTech Health Technologies 
424. Tiger Global Management
425. TogetherMD
426. Torrey Pines
427. TouchPointCare
428. Transtek
429. Trapollo
430. TYLT Ventures
431. TytoCare
432. U.S. Army Medical Research and Development Command (USAMRDC)
433. Unilever Ventures
434. Union Chimique Belge
435. UnitedHealth
436. University Growth Fund
437. University of Colorado
438. Updata Partners
439. UPMC